Identification of EBV-Specific Antigens Following Microinjection of Subgenomic DNA Fragments

  • Ann Boyd
  • Jay Stoerker
  • Jane Holliday
  • Ronald Glaser
Part of the Developments in Medical Virology book series (DIMV, volume 1)


The regions of the Epstein-Barr Virus (EBV) genome which code for proteins within the early antigen (EA) and viral capsid antigen (VCA) complex were identified by indirect immunofluorescence (IF) 2–4 days after microinjection of subgenomic cloned fragments of EBV DNA. Two new regions have been identified as part of the early antigen (EA) complex, namely, the Charon 4A cloned fragments which cover map units 38–47 and 83–93 respectively. One DNA fragment from map units 45–54, produces a protein in human cells after microinjection which reacts with EA-VCA+ human sera. Attempts to transform human B-lymphocytes from cord blood with a variety of EBV DNA fragments is described.


Phate Buffer Saline Early Antigen Viral Capsid Antigen 15ml Conical Centrifuge Tube Subgenomic Fragment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ben-Bassat, H., Mitrani-Rosenbaum, S., and Goldblum, N., Induction of Epstein-Barr virus nuclear antigen and DNA synthesis in a human epithelial cell line after Epstein-Barr virus infection. J. Virol. 41, 703–708, (1982).PubMedGoogle Scholar
  2. Blattner, F.R., Williams, B.G., Blechl, A.E., Denniston-Kiefer, D.O., Moore, D.D., Schumm, J. W., Sheldon, E.L., and Smithies, O., Safer derivatives of bacteriophage lambda for DNA cloning. Science 196, 161–169, (1977).PubMedCrossRefGoogle Scholar
  3. Buell, G.N., Reisman, D., Dintner, C., Crouse, G., and Sugden, B., Cloning overlapping DNA fragments from the B95-8 strain of Epstein-Barr virus reveals a site of homology to the internal repetition. J. Virol 40, 977–982, (1981).PubMedGoogle Scholar
  4. Epstein, M.A., Achong, B.G., and Barr, Y.M., Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1, 702–703, (1964).PubMedCrossRefGoogle Scholar
  5. Glaser, R., De-The, G., Lenoir, G., and Ho, J.H.C., Superinfection of epithelial nasopharyngeal carcinoma cells with Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 73, 960–963, (1976).PubMedCrossRefGoogle Scholar
  6. Glaser, R., Lang, C.M., Lee, K.J., Schuller, D.E., Jacobs, D., and McQuattie, C., Attempt to infect normal nasopharyngeal epithelial cells with the Epstein-Barr virus. J. Nat. Cancer Inst. 64, 1085–1090, (1980).PubMedGoogle Scholar
  7. Glaser, R., Boyd, A., Stoerker, J., and Holliday, J., Functional mapping of the Epstein-Barr virus genome: Identification of sites coding for the restricted early antigen, the diffuse early antigen and the nuclear antigen. Virol. 129, 188–198, (1983).CrossRefGoogle Scholar
  8. Graessmann, A., Wolf, H., and Bornkamm, G.W., Expression of Epstein-Barr virus genes in different cell types after microinjection of viral DNA. Proc. Natl. Acad. Sci. USA 77, 433–436, (1980).PubMedCrossRefGoogle Scholar
  9. Henle, G., Henle, W., and Klein, G. Demonstration of two distinct components on the early antigen complex of Epstein-Barr virus-infected cells. Int. J. Cancer 8: 272–278, (1971).Google Scholar
  10. Hummel, M., and Kieff, E., Mapping of polypeptides encoded by the Epstein-Barr virus genome in productive infection. Proc. Natl. Acad. Sci. USA 79, 5698–5702, (1982).PubMedCrossRefGoogle Scholar
  11. Kishishita, M., Luka, J., Vroman, B., Poduslo, J., and Pearson, G. R., Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen. Virol. 133, 363–375, (1984).CrossRefGoogle Scholar
  12. Klein, G., Luka, J., and Zeuthen, J., Transformation induced by Epstein-Barr virus and the role of the nuclear antigen. Cold Spring Harbor Symp. Quant. Biol. 44, 253–261, (1980).Google Scholar
  13. Laboratory of Tumor Viruses of Cancer Institute and Other Institutions in China. Establishment of an epithelioid cell line and a fusiform cell line from a patient with nasopharyngeal carcinoma. Scientia Sinica 21, 127–134, (1978).Google Scholar
  14. Miller, G., Lisco, H., Kohn, H. I., and Stitt, D., Establishment of cell lines from normal adult blood leukocytes by exposure to Epstein-Barr virus and neutralization by human sera with Epstein-Barr virus antibody. Proc. Soc. Exp. Biol. Med. 137, 1459–1465, (1971).PubMedGoogle Scholar
  15. Pearson, G.R., Vroman, B., Chase, B., Sculley, T., Hummel, M., and Kieff, E., Identification of polypeptide components of the Epstein-Barr virus early antigen complex using monoclonal antibodies. J. Virol. 47, 193–201, (1983).PubMedGoogle Scholar
  16. Pope, J.H., Transformation of the virus in vitro.In“The Epstein-Barr Virus” (M.A. Epstein and B.G. Achong, eds.) Springer-Verlag, Berlin/New York, (1979).Google Scholar
  17. Reedman, B. and Klein, G., Cellular localization of an Epstein-Barr virus (EBV) associated complement fixing antigen in producer and nonproducer lymphoblastoid cell lines. Int. J. Cancer 11, 499–520, (1973).PubMedCrossRefGoogle Scholar
  18. Sixbey, J. W., Vesterimen, E. H., Nedrud, J. G., Raab-Traub, N., Walton, L. A., and Pagano, J. S., Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature 306, 480–483, (1983).PubMedCrossRefGoogle Scholar
  19. Southern, P. J., and Berg, P., Transformation of mammalian cells to antiobiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1, 327–341, (1982).PubMedGoogle Scholar
  20. Stoerker, J., and Glaser, R., Rescue of transforming Epstein-Barr virus (EBV) from EBV genome positive epithelial hybrid cells transfected with subgenomic fragments of EBV DNA. Proc. Natl. Acad. Sci. USA 80, 17261729, (1983).Google Scholar
  21. Summers, W. P., Grogan, E.A., Shedd, D., Robert, M., Liu, C.R., and Miller, G., Stable expression in mouse cells of nuclear neoantigen after transfer of a 3.4 megadalton cloned fragment of Epstein-Barr virus DNA. Proc. Natl. Acad. Sci. USA. 79, 6588–5692, (1982).CrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1985

Authors and Affiliations

  • Ann Boyd
    • 1
  • Jay Stoerker
    • 2
  • Jane Holliday
    • 2
  • Ronald Glaser
    • 2
  1. 1.Department of BiologyHood College and Program Resources, Inc., NCI-Frederick Cancer Research FacilityFrederickUSA
  2. 2.Department of Medical Microbiology and ImmunologyThe Ohio State University College of Medicine and Comprehensive Cancer CenterColumbusUSA

Personalised recommendations